Please use this identifier to cite or link to this item:
https://biore.bio.bg.ac.rs/handle/123456789/2422
Title: | Cyclic AMP response element binding (CREB) protein acts as apositive regulator of SOX3 gene expression in NT2/D1 cells | Authors: | Kovacevic-Grujicic, Natasa Mojsin, Marija Popovic, Jelena Petrovic, Isidora Topalovic, Vladanka Stevanović, Milena |
Keywords: | CREB;NT2/D1 cells;Retinoic acid;SOX3;Transcription regulation | Issue Date: | 2014 | Journal: | BMB Reports | Abstract: | SOX3 is one of the earliest neural markers in vertebrates, playing the role in specifying neuronal fate. In this study we have established first functional link between CREB and human SOX3 gene which both have important roles in the nervous system throughout development and in the adulthood. Here we demonstrate both in vitro and in vivo that CREB binds to CRE half-site located -195 to -191 within the human SOX3 promoter. Overexpression studies with CREB or its dominant-negative inhibitor A-CREB indicate that this transcription factor acts as a positive regulator of basal SOX3 gene expression in NT2/D1 cells. This is further confirmed by mutational analysis where mutation of CREB binding site results in reduction of SOX3 promoter activity. Our results point at CREB as a positive regulator of SOX3 gene transcription in NT2/D1 cells, while its contribution to RA induction of SOX3 promoter is not prominent. © 2014 by the The Korean Society for Biochemistry and Molecular Biology. |
URI: | https://biore.bio.bg.ac.rs/handle/123456789/2422 | ISSN: | 1976-6696 | DOI: | 10.5483/BMBRep.2014.47.4.084 |
Appears in Collections: | Journal Article |
Files in This Item:
File | Description | Size | Format | Existing users please |
---|---|---|---|---|
kovacevicgrujicic2014BMPReports.pdf | 3.28 MB | Adobe PDF | Request a copy |
SCOPUSTM
Citations
4
checked on Nov 17, 2024
Page view(s)
2
checked on Nov 21, 2024
Google ScholarTM
Check
Altmetric
Altmetric
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.